Changeflow GovPing Healthcare & Life Sciences USPTO Patent Grants - Organic Chemistry (C07D)
Favicon for changeflow.com

USPTO Patent Grants - Organic Chemistry (C07D)

RSS

Granted patents in USPTO classification C07D, covering heterocyclic organic compounds: the chemical core of most small-molecule drugs. Around 160 grants a month. Unlike applications, grants are enforceable. This feed is the best public-domain signal of which small-molecule compositions have just become defensible IP, which matters for generic entry timing, freedom-to-operate opinions, and competitive intelligence. Watch this if you practice pharma IP law, manage a drug discovery patent portfolio, advise on compound licensing, or scout ANDA opportunities as brand drugs approach loss of exclusivity. Recent grants cover apalutamide process improvements and bioactive phenolate ionic complexes.

Tuesday, March 24, 2026

Favicon for changeflow.com

USPTO Patent for Acetic Acid Derivatives as Safeners

The USPTO has granted a patent (US12583826B2) to Bayer Aktiengesellschaft for acetic acid derivatives and salts thereof, intended for use as safeners in crop protection compositions. These compounds aim to reduce the phytotoxic effects of agrochemicals, particularly herbicides.

Routine Rule Agriculture
Favicon for changeflow.com

Redona Therapeutics Cancer Treatment Compounds Patent Grant

The USPTO has granted Redona Therapeutics, Inc. a patent (US12583825B2) for novel cancer treatment compounds. The patent covers specific benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives and their use in treating neoplastic diseases.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Grant: Benzylamine Derivative for Anti-Tumor Efficacy

The USPTO has granted a patent (US12583822B2) to the Academy of Military Medical Sciences for a benzylamine derivative with potential anti-tumor efficacy. The patent covers the derivative, its preparation method, and its use in treating PD-1/PD-L1-related diseases.

Routine Rule Pharmaceuticals
Favicon for changeflow.com

Omecamtiv Mecarbil Salt and Preparation Process

The USPTO has granted US Patent 12583821B2 to Cytokinetics, Inc. for a specific salt form of omecamtiv mecarbil and its preparation process. This patent covers the dihydrochloride salt form, related compositions, and methods of use, primarily impacting pharmaceutical development and intellectual property.

Routine Rule Pharmaceuticals
Favicon for changeflow.com

USPTO Patent US12583820B2: Antivirals against coronavirus

The USPTO has granted patent US12583820B2 to Kansas State University Research Foundation for broad spectrum antivirals against coronaviruses. The patent covers specific chemical compounds designed to inhibit viral replication.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Grant US12582652B2 for Ion Channel Modulator

The USPTO has granted patent US12582652B2 to Praxis Precision Medicines, Inc. for a novel ion channel modulator compound. The patent covers methods of treating neurological disorders and conditions associated with neuronal excitability.

Routine Notice Pharmaceuticals

Sunday, March 22, 2026

Favicon for changeflow.com

USPTO Patent Grant US12581852B2 for Luminescent Material

The United States Patent and Trademark Office (USPTO) has granted patent US12581852B2 to KYULUX, INC. for a compound useful as a light-emitting material. The patent covers specific chemical formulas and their application in organic optical devices.

Routine Notice Intellectual Property
Favicon for changeflow.com

Samsung Display Patent for Organic Compound Sensor Display

The USPTO has granted Samsung Display Co., Ltd. a patent for an organic compound sensor display. The patent, US12581853B2, covers an organic compound represented by Chemical Formula 1 and its application in sensor-embedded display panels and electronic devices. The filing date was September 28, 2022.

Routine Notice Intellectual Property
Favicon for changeflow.com

USPTO Patent Grant for Light-Emitting Element

The USPTO has granted patent US12581794B2 for a light-emitting element developed by Semiconductor Energy Laboratory Co., Ltd. The patent covers a specific design for a light-emitting element utilizing a phosphorescent compound and an exciplex formed by organic compounds.

Routine Notice Intellectual Property
Favicon for changeflow.com

USPTO Patent Grant: Bioprobes for Amine Oxidase Enzymes

The USPTO has granted a patent (US12578335B2) to Syntara Limited for novel bioprobes designed to detect and quantify amine oxidase enzymes. These bioprobes are intended for use in assessing enzyme concentrations and inhibition levels in various samples.

Routine Rule Pharmaceuticals

Showing 151–160 of 160 changes

1 2 3 4

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source details

Activity

Changes tracked
160
Changes in last month
110
Last change detected
7d ago

Filters

Get USPTO Patent Grants - Organic Chemistry (C07D) alerts

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!